Andlauer Healthcare Group Inc.
AND.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 115.73M | 120.22M | 117.02M | 117.98M | 119.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 115.73M | 120.22M | 117.02M | 117.98M | 119.52M |
| Cost of Revenue | 77.62M | 79.42M | 76.98M | 78.51M | 80.65M |
| Gross Profit | 38.10M | 40.81M | 40.03M | 39.48M | 38.87M |
| SG&A Expenses | 10.58M | 9.12M | 9.84M | 10.41M | 9.51M |
| Depreciation & Amortization | 12.50M | 12.59M | 12.74M | 12.86M | 13.60M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 100.70M | 101.12M | 99.56M | 101.78M | 103.76M |
| Operating Income | 15.03M | 19.10M | 17.45M | 16.21M | 15.76M |
| Income Before Tax | 17.73M | 17.22M | 16.32M | 15.69M | 15.11M |
| Income Tax Expenses | 3.64M | 4.69M | 4.38M | 4.20M | 4.04M |
| Earnings from Continuing Operations | 14.09M | 12.52M | 11.94M | 11.50M | 11.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.09M | 12.52M | 11.94M | 11.50M | 11.07M |
| EBIT | 15.03M | 19.10M | 17.45M | 16.21M | 15.76M |
| EBITDA | 19.18M | 38.77M | 29.82M | 20.38M | 29.36M |
| EPS Basic | 0.36 | 0.32 | 0.30 | 0.28 | 0.27 |
| Normalized Basic EPS | 0.23 | 0.27 | 0.26 | 0.24 | 0.23 |
| EPS Diluted | 0.36 | 0.32 | 0.30 | 0.28 | 0.26 |
| Normalized Diluted EPS | 0.22 | 0.27 | 0.26 | 0.23 | 0.22 |
| Average Basic Shares Outstanding | 39.24M | 39.24M | 39.39M | 41.11M | 41.38M |
| Average Diluted Shares Outstanding | 39.85M | 39.75M | 39.96M | 41.76M | 42.11M |
| Dividend Per Share | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 |
| Payout Ratio | 23.25% | 24.63% | 26.54% | 25.12% | 27.69% |